Chemotherapy only in early-stage Hodgkin lymphoma: More relapses but “same” (or possibly worse) survival – Reconsidering the misguided trend to omit radiotherapy
The standard treatment of early-stage Hodgkin lymphoma (ESHL) as recommended by most national guidelines is combined modality treatment (CMT) that includes a short course ABVD followed by a small field of low dose radiotherapy (RT). Recently a trend to treat patients with more chemotherapy alone has...
| Main Author: | |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Springer US
2014
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4180027/ |